Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Mermin

Showing results (91-100 of 170) with videos related to

Pageof 17
Sort By:
AIDS Research and Therapy|January 20, 2007
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass indexDavid M Moore, Anna Awor, Robert S Downing, et al.
AIDS (London, England)|April 28, 2011
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-upRose Apondi, Rebecca Bunnell, John Paul Ekwaru, et al.
Journal of Public Health Management and Practice : JPHMP|February 14, 2015
Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons TestedSamah Hayek, Patricia M Dietz, Michelle Van Handel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donorsWolfgang Hladik, Sheila C Dollard, Robert G Downing, et al.
AIDS and Behavior|May 23, 2006
Desire for children and pregnancy risk behavior among HIV-infected men and women in UgandaSylvia Nakayiwa, Betty Abang, Laura Packel, et al.
JAMA|August 2, 2002
An outbreak of food-borne illness associated with methomyl-contaminated saltUdo Buchholz, Jonathan Mermin, Richard Rios, et al.
BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.
AIDS Patient Care and Stds|September 10, 2008
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural UgandaPaul J Weidle, David Moore, Jonathan Mermin, et al.
Kidney International|July 11, 2008
Antiretroviral therapy improves renal function among HIV-infected UgandansPhilip J Peters, David M Moore, Jonathan Mermin, et al.
Pageof 17

Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
AIDS Research and Therapy|January 20, 2007
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass indexDavid M Moore, Anna Awor, Robert S Downing, et al.
AIDS (London, England)|April 28, 2011
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-upRose Apondi, Rebecca Bunnell, John Paul Ekwaru, et al.
Journal of Public Health Management and Practice : JPHMP|February 14, 2015
Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons TestedSamah Hayek, Patricia M Dietz, Michelle Van Handel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donorsWolfgang Hladik, Sheila C Dollard, Robert G Downing, et al.
AIDS and Behavior|May 23, 2006
Desire for children and pregnancy risk behavior among HIV-infected men and women in UgandaSylvia Nakayiwa, Betty Abang, Laura Packel, et al.
JAMA|August 2, 2002
An outbreak of food-borne illness associated with methomyl-contaminated saltUdo Buchholz, Jonathan Mermin, Richard Rios, et al.
BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.
AIDS Patient Care and Stds|September 10, 2008
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural UgandaPaul J Weidle, David Moore, Jonathan Mermin, et al.
Kidney International|July 11, 2008
Antiretroviral therapy improves renal function among HIV-infected UgandansPhilip J Peters, David M Moore, Jonathan Mermin, et al.
Pageof 17